Hi. Fahmy et al., PRIMARY HYPERALDOSTERONISM CAUSING POSTTRANSPLANTATION HYPERTENSION -LOCALIZATION BY ADRENAL VEIN SAMPLING, American journal of kidney diseases, 31(5), 1998, pp. 853-855
A 58-year-old man with end-stage renal disease who had received a cada
veric renal transplant presented with persistent hypertension and hypo
kalemia. Allograft renal artery stenosis, rejection, and cyclosporine
effects were excluded. Hypokalemia persisted despite potassium supplem
entation and antihypertensive medications with hyperkalemic effects. T
he biochemical findings of primary hyperaldosteronism with a normal ad
renal anatomy imaged by magnetic resonance imaging (MRI) necessitated
adrenal vein sampling to lateralize a left adrenal adenoma. His hypoka
lemia was cured by the removal of the adenoma, and his blood pressure
(BP) control was easily achieved with a less complex regimen of antihy
pertensives. We suggest that the concomitant existence of resistant hy
pokalemia and posttransplantation hypertension, especially in the cycl
osporine era, should stimulate a search for hyperaldosteronism; once t
ransplant renal artery stenosis has been excluded, the patient should
be investigated for primary hyperaldosteronism. When imaging studies f
ail to show adrenal pathology, adrenal vein sampling will likely do so
. (C) 1998 by the National Kidney Foundation, Inc.